Employers Grapple With Cost of ObamaCare
Employers continue to grapple with the ObamaCare’s implementation and its various requirements, with companies like UPS voicing more concern over the cost of complying with the new health law.
Ahead of ObamaCare Deadline, Health Insurers Canceling Thousands of Policies That Fall Short of ACA Rules
As the Affordable Care Act’s rocky rollout continues, hundreds of thousands of individuals nationwide are receiving notices from their insurers that their current policies are being terminated.
ObamaCare’s Second Week: A Tale of Two Exchanges
The Affordable Care Act’s second week of open enrollment continued on its bumpy path, but the state-run exchanges are moving to the head of the class.
New Deadline for Insurance Mandate?
Those looking to avoid penalties under the individual mandate portion of the Affordable Care Act reportedly have to sign up for coverage by Feb. 14, 2014, six weeks before the exchanges’ open enrollment period ends.
ObamaCare’s Mystery Number: Just How Many People Signed Up?
When it comes to just how many people signed up for health care insurance on the exchanges last week, the administration is remaining mum. Here’s a look at the latest comments, and why it may be too soon to ask for enrollment numbers.
McAfee: Beware of ObamaCare Phishing Scams
McAfee warned the launch of health-care exchanges will likely inspire phishing attacks aimed at stealing personal information.
Another Hospital Deal? Rivals Reportedly Circle $4B Health Management
The U.S. hospital operator has reportedly received buyout interest from Community Health Systems and others.
High Court Rules FTC can Challenge 'Pay to Delay' Deals
In a 5-3 vote, the Supreme Court ruled the Federal Trade Commission can challenge deals brand-name drug companies make with generic rivals that keep cheaper products off the market.
Buzz Kill: FDA Will Investigate Added Caffeine
Food regulators are looking into the potential impact of Wrigley's new Alert Energy Caffeine Gum on children and adolescents.
UPS Inks $40M Deal to Settle Illegal Online Pharmacy Charges
The shipping giant agreed to forfeit $40 million in payments received from doing business with illicit online pharmacies.
SEC Investigates Allegations of Misspending by Dow Chemical CEO: Sources
The U.S. Securities and Exchange Commission is investigating allegations that Andrew Liveris, chairman and chief executive officer of industrial giant Dow Chemical, misused company funds for personal benefit, according to people familiar with the matter.
Ex-Drug Executive Shkreli Invokes Fifth Amendment Before Congress
Former Turing Pharmaceuticals Chief Executive Officer Martin Shkreli invoked his Fifth Amendment right against self-incrimination and declined to answer questions from U.S. lawmakers.
How Nancy Reagan Changed the Way Americans View Alzheimer’s
Former first lady Nancy Reagan was a ‘true champion’ of Alzheimer’s disease.
WebMD Removes 'Interim' Title From CEO, Taps President
WebMD elevated David Schlanger to the permanent CEO position after the company veteran served a three-month stint as interim CEO.
Apple Wants to Transform Your Doctor Visits
On Wednesday, Apple executives spoke about how their new Apple Watch is going to change health care.
BlackBerry Buys Minority Stake In Health-Care Cloud Firm
BlackBerry bought a minority stake in health IT firm NantHealth in a bid to improve data sharing and communication in the health-care industry.
British court rules in favor of patent protecting Lilly lung cancer treatment Alimta
Eli Lilly received some European legal backing for its top product, the lung cancer treatment Alimta, on Thursday when a British court upheld a patent protecting a vitamin regimen administered with the drug.
Unreleased financials freeze shares of Morgan Stanley-backed companies
Two major companies in a prominent $1.4 billion Asia investment fund managed by banking giant Morgan Stanley failed to file their financial statements on time, freezing trading in their stocks.
Merck gives free license allowing cheap versions of its HIV drug for children in poor nations
Drugmaker Merck has granted a free license allowing one of its HIV medicines to be made and sold inexpensively for use in young children in poor countries hard hit by the AIDS virus.
Supreme Court sides with Teva in patent dispute over multiple sclerosis drug
The Supreme Court has sided with Teva Pharmaceutical Industries Ltd. in the company's high-profile patent dispute with rival firms over the top-selling multiple sclerosis drug.















